Viewing Study NCT06650761


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2025-12-30 @ 3:00 AM
Study NCT ID: NCT06650761
Status: RECRUITING
Last Update Posted: 2025-09-10
First Post: 2024-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of CDX-622
Sponsor: Celldex Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module